1 Min Read
Nov 9 (Reuters) - KemPharm Inc
* KemPharm reports third quarter 2017 results and provides corporate update
* Q3 loss per share $0.68
* Q3 earnings per share view $-0.67 — Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.